SeaStar Medical Holding Corp (ICU)
0.4486
-0.04
(-9.06%)
USD |
NASDAQ |
May 03, 16:00
0.4551
+0.01
(+1.45%)
After-Hours: 20:00
SeaStar Medical Research and Development Expense (Quarterly): 1.075M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.075M |
| September 30, 2023 | 1.107M |
| June 30, 2023 | 2.007M |
| March 31, 2023 | 1.784M |
| December 31, 2022 | 0.825M |
| Date | Value |
|---|---|
| September 30, 2022 | 0.727M |
| June 30, 2022 | 0.596M |
| March 31, 2022 | 0.355M |
| June 30, 2021 | 0.536M |
| March 31, 2021 | 0.746M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.355M
Minimum
Mar 2022
2.007M
Maximum
Jun 2023
0.9758M
Average
0.7855M
Median
Research and Development Expense (Quarterly) Benchmarks
| Nuwellis Inc | 1.372M |
| Ardelyx Inc | 9.524M |
| Adverum Biotechnologies Inc | 15.28M |
| Aquestive Therapeutics Inc | 2.888M |
| Vir Biotechnology Inc | 111.92M |